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Introduction
The mass administration of antibiotics has been used in the prevention and treatment of bacterial diseases. It has been recognized as a potentially vital and important public health strategy towards the control of neglected tropical diseases and other coinfections in sub-Saharan Africa, whereby the provision of universal healthcare is still a major challenge. It has also been considered as a cost-effective method because of geographic overlaps of various diseases and high level of poverty in the region. Despite this, the secondary health benefits effects of such a programme have not been fully expounded, especially in developing countries whereby provision of universal healthcare is still a major challenge. The purpose of this study was to investigate the secondary benefits arising from the mass administration of azithromycin, an antibiotic in the mass treatment of active trachoma in an economically challenged Kenyan nomadic community. This was achieved by examining the trends of diseases two years before, and after the drug administration. The administration of azithromycin was part of the SAFE strategy (Surgery, Antibiotics, Facial and Environmental cleanliness) conducted in Narok district in Kenya from 2007 to 2010.
The F&E components had not been fully implemented in the entire district at the time of this study. The findings were compared with those of neighbouring Transmara district, which is trachomaendemic but had no trachoma control project.
Trachoma is still endemic in developing countries and is the common cause of infectious blindness. Most of the afflicted are poor people with low hygiene and inadequate access to clean water.
They are therefore vulnerable to several other infections [1, 2] . As a strategy to eradicate trachoma, the World Health Organization (WHO) adopted the SAFE programme consisting of Surgery, Antibiotics for infectious trachoma, Facial cleanliness to reduce transmission and Environmental cleanliness to improve hygiene and sanitation. It recommends mass distribution of antibiotic in affected areas with prevalence of active trachoma of more than 10% in children aged 1 to 9 years in a district, or 5% for the community [3, 4] .
Trachoma control programs in some of districts are currently on going in Kenya. The SAFE programme, implemented in Shampole, Kajiado district reported reduction in prevalence of active trachoma from 46% to 16% and the potentially blinding trachoma from 4.5% to 1.7% over a period of one year with low incidences of recurrences [5] . SAFE strategy programme in the greater Narok district began in 2008 and proceeded annually for three years, with the support from Operation Eyesight Universal (OEU). The prevalence of trachoma in Narok district is 30.5% [6] . Azithromycin is currently the antibiotic of choice administered in repeated annual community mass treatment for a period of three years [7] . It is administered as a single dose of 1 gm for adults whereas the children's dose is 20 mg/kg. Expectant mothers and children less than six months are put on tetracycline eye ointment [8] . The F&E activities involve preventive measures to reduce disease transmission which includes the provision of water, health promotion and education. The full benefits of the F&E activities generally take a longer period to be realized owing to the challenges of its implementation [9] [10] [11] .
Previous studies have demonstrated that azithromycin markedly decreases the prevalence of ocular strains of Chlamydia trachomatis, the causative agent for trachoma [12, 13] . Whereas mass treatment has been shown to reduce the prevalence of trachoma, the potential secondary health benefits of such treatment have not been well documented. Previous studies regarding its impact on the prevalence of respiratory infections have been inconclusive. In a study among children in Ethiopia, the authors reported a decline in the overall mortality, perhaps due to respiratory infections, diarrhoea and malaria [14, 15] . An indirect protective effect against trachoma among untreated children residing in villages where most individuals have been treated, and decline in pneumococcal resistance has also been reported after mass treatment in Ethiopia [16, 17] . However, other authors in related studies concluded that it may lead to the emergence of resistant strains of Streptococcus pneumonia [18, 19] . The aim of this study therefore, was to investigate the potential secondary benefits arising from the mass treatment.
Methods
This community based operational research was conducted in the Transmara to determine whether the treatment was beneficial or not. At the time of the study, F&E activities in Narok were at its inception and had not achieved a wider coverage. In both Narok and Transmara districts, there were F&E activities being provided under the National Community Health Strategy programme. It was therefore assumed that any change in disease patterns was attributable to the MDA. We also reported the trends in the diseases.
Statistical analysis
The number of patients treated in each month was aggregated to the totals for the year. The base year analysis was set to 2007, 
Results
The mass distribution coverage in Narok district decreased over the study period; 83% in 2008, 74% in 2009 and 63% in 2010.
Respiratory diseases and malaria were the most prevalent diseases.
The prevalence of pneumonia was between 5% and 7% while that of the other diseases of the respiratory system ranged from 30% to 34%. Malaria had a prevalence of between 22% and 29% over the study period. The prevalence of the other infections recorded is as in Table 1 . Apart from the diarrhoeal diseases, there was a general decline in all the other recorded infectious diseases after the third year from the baseline, despite the decreased percentage coverage over the period (Table 1, Figure 1 ). Respiratory diseases were significantly more prevalent in the years prior to the intervention compared to the period after the use of antibiotics. The proportions of patients with malaria decreased throughout the study period. The prevalence for both diseases rose proportionately with the corresponding decrease in coverage from the second to the third round (malaria 25% vs. 22%, respiratory diseases 31% vs. 30%).
There was a statistically significant increase in proportion of pneumonia during this period (Figure 1 ).There were statistically significant changes in the odds for all diseases except skin diseases three rounds after the intervention. The odds for malaria (68580(27%) vs. 63900(25%); OR, 1.13; 95% CI 1.12-1.14), In Transmara (control), there was an increase in the odds for malaria, respiratory infections, UTIs and intestinal worms. The odds for diarrhoeal diseases, skin diseases and pneumonia decreased but significantly in this case, the odds decreased throughout the period 
Discussion
The provision of basic healthcare is still a major challenge in developing countries and respiratory diseases, malaria and diarrhoea have been identified as the leading death of children in developing countries [20] [21] [22] Previous studies have demonstrated that this strategy is a costeffective method because of the geographic overlaps of the various diseases and the high level of poverty in the region. It has also been shown to be safe and efficacious [26, 27] . Our study was set in a community that is poor and of low hygiene, and therefore quite vulnerable to several diseases due to inaccessibility of water and sanitation among other problems. The provision of health services is also a major challenge owing to their pastoralist and nomadic way of life. The purpose of our study was to investigate the potential benefits arising from the mass administration of azithromycin in resource-limiting settings. We utilized the data from an existing programme for the control of infectious trachoma to determine the potential secondary effects resulting from mass administration of azithromycin. Our results suggest that the mass administration of azithromycin may have some secondary beneficial effects. there was a reported decrease in the prevalence of malaria and diarrhoea [14, 17] . In a separate study conducted in Gambia, the authors concluded that it reduced the childhood morbidity [34] . A recent study, also conducted in Ethiopia concluded that mass administration of azithromycin in a trachoma control programme reduced all-cause and infections childhood mortality [15] . We There are several limitations in our study. We did not obtain data on the demographics of the patients and were therefore unable to determine the extent any confounding factors to the results. Some patients may not have been seen after the administration of azithromycin. We also made the assumption that the diagnosis was 
Conclusion
Our findings demonstrate that the mass distribution of azithromycin may have contributed to the decrease in the prevalence of the respiratory infections in Narok District.
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